Insulet Corp.

PODD

$150.58

+1.65%

N/A+$2.44

Healthcare

Medical - Devices

NASDAQ

Active Trading

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company ...

Financial Highlights of PODD

Profitability trend

Latest / TTM · 6 periods

Gross Margin

71.1%

Net Margin

12.3%

P/E Ratio

28.09x

n/a

Debt / Equity

0.67

n/a

Current Ratio

2.48

Dividend Yield

0.0%

Understanding

TTM —

No major balance sheet stress in these headline ratios.

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

71.1%

Net Margin

12.3%

P/E Ratio

28.09x

Debt / Equity

0.67

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	68.4%	61.7%	68.3%	69.8%	71.6%	—
Operating MarginOperating income as a percentage of revenue.	11.5%	2.9%	13.0%	14.9%	17.5%	—
Net MarginNet income as a percentage of revenue.	1.5%	0.4%	12.2%	20.2%	9.1%	—
EBITDA MarginEBITDA divided by revenue.	12.7%	8.4%	19.1%	20.5%	19.7%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	1.9%	0.8%	12.6%	14.5%	12.5%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	5.75	3.56	3.47	3.54	2.78	—
Quick RatioLiquid assets divided by current liabilities.	4.43	2.61	2.58	2.73	2.11	—
Cash RatioCash and equivalents divided by current liabilities.	3.46	1.71	1.44	1.80	1.05	—
Debt / AssetsDebt as a share of total assets.	62.8%	63.6%	56.0%	46.1%	32.9%	—
Debt / EquityDebt compared with shareholder equity.	2.31	3.01	1.98	1.17	0.69	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	6.82x	6.35x	4.72x	5.67x	5.24x	—
Inventory TurnoverHow often inventory is sold in a year.	1.14x	1.44x	1.33x	1.45x	1.70x	—
Payables TurnoverHow often payables are paid in a year.	9.20x	16.22x	27.98x	31.61x	10.24x	—
Asset TurnoverRevenue generated per dollar of assets.	0.54x	0.58x	0.66x	0.67x	0.85x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	1.04x	1.29x	1.66x	1.69x	2.12x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	1064.28x	4440.27x	73.30x	43.73x	80.98x	—
P/B RatioPrice paid for each dollar of book value.	32.38x	42.87x	20.66x	15.10x	13.20x	—
P/S RatioPrice paid for each dollar of sales.	16.39x	15.65x	8.92x	8.83x	7.38x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-94.40x	-533.25x	215.90x	59.90x	52.94x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer